- Home
- SNY vs GSL Comparison
SNY vs GSL Comparison
Compare SNY & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- GSL
- Stock Information
- Founded
- SNY 1994
- GSL 2007
- Country
- SNY France
- GSL Greece
- Employees
- SNY N/A
- GSL N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- GSL Marine Transportation
- Sector
- SNY Health Care
- GSL Consumer Discretionary
- Exchange
- SNY Nasdaq
- GSL Nasdaq
- Market Cap
- SNY 116.1B
- GSL 1.0B
- IPO Year
- SNY N/A
- GSL 2006
- Fundamental
- Price
- SNY $51.62
- GSL $28.44
- Analyst Decision
- SNY Buy
- GSL Strong Buy
- Analyst Count
- SNY 4
- GSL 1
- Target Price
- SNY $61.50
- GSL $33.00
- AVG Volume (30 Days)
- SNY 3.3M
- GSL 318.4K
- Earning Date
- SNY 10-24-2025
- GSL 11-10-2025
- Dividend Yield
- SNY 3.10%
- GSL 7.38%
- EPS Growth
- SNY 105.93
- GSL 19.05
- EPS
- SNY 8.67
- GSL 10.76
- Revenue
- SNY $53,890,648,839.00
- GSL $730,277,000.00
- Revenue This Year
- SNY $1.40
- GSL $5.44
- Revenue Next Year
- SNY $6.67
- GSL N/A
- P/E Ratio
- SNY $11.75
- GSL $2.65
- Revenue Growth
- SNY N/A
- GSL 4.04
- 52 Week Low
- SNY $44.62
- GSL $17.73
- 52 Week High
- SNY $60.12
- GSL $33.08
- Technical
- Relative Strength Index (RSI)
- SNY 64.11
- GSL 39.47
- Support Level
- SNY $49.62
- GSL $27.81
- Resistance Level
- SNY $50.47
- GSL $28.96
- Average True Range (ATR)
- SNY 0.70
- GSL 0.71
- MACD
- SNY 0.18
- GSL 0.01
- Stochastic Oscillator
- SNY 86.67
- GSL 39.07
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.